Compugen Ltd.
CGEN | NASDAQ
$2.00
-$0.04 (-1.96%)
At close: Oct 30, 2026, 3:59 PM ET
$1.98
-$0.02 (-1.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-1.96%
(1D)No price chart data available for 1D timeframe.
Rating
85.8
+5.0 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #3/1028 (Top 1%)
Key Statistics
Market Data
Market Cap $188.97M
1D Range
1.93 2.03
52W Range
1.47 3.10
Valuation (TTM)
PE 5.26
PB 2.13
EV/EBITDA 1.89
Valuation (NTM)
Forward PE N/A
Forward PEG -0.79
Price Target $5.00
Cash Flow
FCF Yield 0.0%
SBC Adj. FCF Yield 0.0%
SBC Impact N/A
Margins
Gross Margin 86.9%
Operating Margin 40.9%
FCF Margin 0.0%
Growth (CAGR)
Revenue 3Y | 5Y 114.5% |
105.9%
Dil EPS 3Y | 5Y 1028.6% |
122.5%
FCF 3Y | 5Y 225.8% |
66.4%
Returns
ROA 25.4%
ROE 42.6%
ROIC 26.0%
Financial Health
Net Cash
$125.3M
Current Ratio 5.72
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and p...
Sector Healthcare
Industry Biotechnology
Employees 75
IPO Date Aug 11, 2000
Website cgen.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+150.00%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CGEN